Your session is about to expire
← Back to Search
Home-Based Integrated Care Nudge for Heart Failure (AHCAH Trial)
N/A
Waitlist Available
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
At least 18 years of age
Admitted to a cardiology or hospitalist service
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-12 months
Awards & highlights
AHCAH Trial Summary
This trialwill test whether a simple "nudge" to enroll seriously ill heart failure patients in home-based integrated care will reduce healthcare costs and improve outcomes.
Who is the study for?
This trial is for adults over 18 with heart failure who live in a specific area and have had a related health care visit within the last year. They must be hospitalized during the study period, not pregnant, incarcerated, homeless, or without a primary physician.Check my eligibility
What is being tested?
The trial tests if 'nudging' clinicians to discuss and enroll seriously ill heart failure patients into an at-home care program can reduce healthcare use and costs while improving end-of-life care compared to usual practices.See study design
What are the potential side effects?
Since this trial involves healthcare management rather than medication or procedures, traditional side effects are not applicable. However, changes in care may affect patient comfort and satisfaction.
AHCAH Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I am currently under the care of a cardiology or hospitalist service.
AHCAH Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6-12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acute care days
Secondary outcome measures
Hospice enrollment
Mortality
Pennsylvania emergency department visits
+8 moreAHCAH Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: AHCAH NudgeExperimental Treatment1 Intervention
The investigators have developed methods for sending "nudges" to clinicians via secure text messages to primary teams to alert them that their patient was identified as high-risk for 6-month mortality and that an AHCAH liaison would visit their patient to discuss the AHCAH program and to facilitate enrollment if the patient was amenable. The investigators propose that these secure text messages would be sent to the teams of patients randomized to the intervention by the AHCAH liaison within 72 hours of eligibility identification (to allow for the liaison not being available over the weekend). The investigator team will track all aspects of messaging and timing. Clinicians can choose to opt out a patient from the liaison visit and AHCAH enrollment within a two-hour timeframe.
Group II: ControlActive Control1 Intervention
Usual Care
Find a Location
Who is running the clinical trial?
Independence Blue CrossUNKNOWN
6 Previous Clinical Trials
125,837 Total Patients Enrolled
1 Trials studying Heart Failure
225 Patients Enrolled for Heart Failure
University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,879,388 Total Patients Enrolled
42 Trials studying Heart Failure
6,814 Patients Enrolled for Heart Failure
Penn Medicine Center for Health Care InnovationUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.Your Palliative Connect score is higher than 0.3.You live outside the area where Caring Way can provide services.People without a permanent place to live.I was diagnosed with heart failure in the last year.You were admitted to the hospital while the study is happening.I am under 18 years old.I am currently under the care of a cardiology or hospitalist service.
Research Study Groups:
This trial has the following groups:- Group 1: AHCAH Nudge
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any spots open in this experiment currently?
"The information featured on clinicaltrials.gov reveals that this trial is no longer recruiting patients, as it was posted in November 2018 and last edited in October 2022. Nevertheless, 780 other trials are currently enrolling individuals for participation."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger